Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 205

The DOI matches its Crossref record.

The Prevalence and Natural History of Dominant Optic Atrophy Due to OPA1 Mutations

Open access
Yu-Wai-Man, Patrick, Griffiths, Philip G., Burke, Ailbhe, Sellar, Peter W., Clarke, Michael P., Gnanaraj, Lawrence, Ah-Kine, Desiree, Hudson, Gavin, Czermin, Birgit, Taylor, Robert W., Horvath, Rita, Chinnery, Patrick F. · 2010 · Ophthalmology

Abstract

Purpose Autosomal dominant optic atrophy (DOA) is a major cause of visual impairment in young adults and it is characterized by selective retinal ganglion cell loss. In order to define the prevalence and natural history of this optic nerve disorder, we performed a population-based epidemiological and molecular study of presumed DOA cases in the north of England. Design Case series Participants Seventy-six affected probands with a clinical diagnosis of DOA were identified from our neuro-ophthalmology and neurogenetics database. Methods OPA1 genetic testing was performed using a PCR-based sequencing strategy. OPA1 negative cases were then screened for large-scale OPA1 re-arrangements and OPA3 mutations. Additional affected family members identified through contact tracing were examined and longitudinal visual data was analyzed. Main Outcome Measures The prevalence and molecular characteristics of DOA in the north of England. Visual function and disease progression among patients with OPA1 positive mutations. Results The detection rate of OPA1 mutations was 57.6% among probands with a positive family history of optic atrophy (19/33) and 14.0% among singleton cases (6/43). About two-thirds of our DOA families harbored OPA1 mutations (14/22, 63.6%), and five novel OPA1 mutations were identified. Only one family carried a large-scale OPA1 rearrangement and no OPA3 mutations were found in our optic atrophy cohort. The minimum point prevalence of DOA in the north of England was 2.87 per 100,000 (95% CI 2.54-3.20), or 2.09 per 100,000 (95% CI 1.95-2.23) when only OPA1 positive cases were considered. Snellen visual acuity varied markedly between OPA1 positive cases with a mean of 20/173 (Range 20/20-hand movement), and visual function worsened in 67.4% of patients during follow-up. The mean rate of visual loss was 0.032 LogMAR/years but some patients experienced much faster visual decline (Range = 0–0.171 LogMAR/years). OPA1 missense mutations were associated with a significantly worse visual outcome compared to other mutational subtypes (P = 0.0001). Conclusions DOA causes significant visual morbidity and affects at least 1 in 35,000 of the general population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ophtha.2009.12.038

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 205

Metadata

Authors
Yu-Wai-Man, P., Griffiths, P. G., Burke, A., Sellar, P. W., Clarke, M. P., Gnanaraj, L., Ah-Kine, D., Hudson, G., Czermin, B., Taylor, R. W., Horvath, R., & Chinnery, P. F.
Venue
Ophthalmology
Publisher
Elsevier BV
Published
2010-08
Volume
117
Issue
8
Pages
1538-1546.e1
ISSN
0161-6420 (ISSN-L)
OpenAlex
W2071118353
Cited by
205
References
0
FWCI
10.55
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Prevalence and Natural History of Dominant Optic Atrophy Due to OPA1 Mutations. https://app.cochat.ai/papers/10.1016/j.ophtha.2009.12.038
The paper
Yu-Wai-Man, P., Griffiths, P. G., Burke, A., Sellar, P. W., Clarke, M. P., Gnanaraj, L., Ah-Kine, D., Hudson, G., Czermin, B., Taylor, R. W., Horvath, R., & Chinnery, P. F. (2010). The Prevalence and Natural History of Dominant Optic Atrophy Due to OPA1 Mutations. Ophthalmology. https://doi.org/10.1016/j.ophtha.2009.12.038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.